1Maximum androgen blockade in advanced prostate cancer:an overview of the randomised trials.Prostate Cancer Trialists′ Collaborative Group.Lancet,2000,355:1491-1498.
2Labrie F,Candas B,Gomez JL,et al.Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology,2002,60:115-119.
3Klotz L,Schellhammer P,Carroll K.A re-assessment of the role of combined androgen blockade for advanced prostate cancer.BJU Int,2004,93:1177-1182.
4Bennett CL,Matchar D,McCrory D,et al.Cost-effective models for flutamide for prostate carcinoma patients:are they helpful to policy makers? Cancer,1996,77:1854-1861.
5Penson DF,Ramsey S,Veenstra D,et al.The cost-effectiveness of combined androgen blockade with bicalutamide and LHRH agonist in men with stage D2 prostate cancer.J Urol,2005,173(4 Suppl):8.
6Bono AU,Pagano F,Montironi R,et al.Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer:progress pathology report of the Italian prosit study.Urology,2001,57:117-121.
7Monfette G,Dupont A,Labrie F,et al.Multiple advantages of prior and post-radical prostatectomy with combined endocrine therapy.Eur Urol,1990,18 Suppl 1:97.
8Schulman CC,Debruyne FM,Forster G,et al.4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer.European Study Group on Neoadjuvant Treatment of Prostate Cancer.Eur Urol,2000,38:706-713.
9Scolieri MJ,Altman A,Resnick MI.Neoadjuvant hormonal ablative therapy before radical prostatectomy:a review.Is it indicated? J Urol,2000,164:1465-1472.
10Gleave ME,Goldenberg SL,Chin JL,et al.Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy:biochemical and pathological effects.J Urol,2001,166:500-506.
